{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:45:00Z","timestamp":1786995900532,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.pnpbp.2013.08.007","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T05:03:20Z","timestamp":1377666200000},"page":"111-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans"],"prefix":"10.1016","volume":"47","author":[{"given":"William W.","family":"Stoops","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Adam","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Lile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar J.","family":"Sevak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2013.08.007_bb0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1037\/a0014398","article-title":"Medications for stimulant abuse: agonist-based strategies and preclinical evaluations of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify)","volume":"16","author":"Bergman","year":"2008","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1037\/1064-1297.3.4.371","article-title":"Role of dopamine in d-amphetamine-induced euphoria in normal, healthy volunteers","volume":"3","author":"Brauer","year":"1995","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0006-3223(95)00110-7","article-title":"Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers","volume":"39","author":"Brauer","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0091-3057(96)00240-7","article-title":"High dose pimozide does not block amphetamine-induced euphoria in normal volunteers","volume":"56","author":"Brauer","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-009-1611-7","article-title":"Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder","volume":"206","author":"Chernoloz","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0030","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/add.12073","article-title":"Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial","volume":"108","author":"Coffin","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00008877-199712000-00002","article-title":"Choice between money and intranasal heroin in morphine maintained humans","volume":"8","author":"Comer","year":"1997","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(97)01572-0","article-title":"Effects of an alternative reinforcer on intravenous heroin self-administration by humans","volume":"345","author":"Comer","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0045","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.104.071035","article-title":"Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors","volume":"311","author":"Czoty","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0050","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1523\/JNEUROSCI.09-06-02051.1989","article-title":"Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis","volume":"9","author":"Kuczenski","year":"1989","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0060","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/sj.npp.1300803","article-title":"Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of d-amphetamine in humans","volume":"30","author":"Lile","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0055","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1177\/0269881110385597","article-title":"Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans","volume":"25","author":"Lile","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2012.10.009","article-title":"Fine-grain analysis of treatment effect of topiramate on methamphetamine addiction with latent variable analysis","volume":"130","author":"Ma","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0070","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2165\/00023210-200216110-00008","article-title":"Aripiprazole","volume":"16","author":"McGavin","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3758\/BF03203313","article-title":"An automated version of the digit symbol substitution test (DSST)","volume":"14","author":"McLeod","year":"1982","journal-title":"Behav Res Methods Instrum"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002130050044","article-title":"Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats","volume":"148","author":"Munzar","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0085","first-page":"239","article-title":"Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats","volume":"291","author":"Munzar","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0090","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1017\/S1461145708009097","article-title":"Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers","volume":"11","author":"Newton","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/ceps.2000.1040","article-title":"Measures of effect size for comparative studies: applications, interpretations and limitations","volume":"25","author":"Olejnik","year":"2000","journal-title":"Contemp Educ Psychol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0100","first-page":"885","article-title":"Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports","volume":"261","author":"Oliveto","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00004714-200106000-00005","article-title":"Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans","volume":"21","author":"Rush","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.102.048439","article-title":"Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans","volume":"306","author":"Rush","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF02311178","article-title":"The discriminative stimulus effects of methamphetamine in pigeons","volume":"120","author":"Sasaki","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0120","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.addbeh.2004.02.013","article-title":"The context of sexual risk behavior among heterosexual methamphetamine users","volume":"29","author":"Semple","year":"2004","journal-title":"Addict Behav"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/FBP.0b013e32833fa7b3","article-title":"Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule","volume":"21","author":"Sevak","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0130","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/JCP.0b013e318221b2db","article-title":"Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole","volume":"31","author":"Sevak","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2004.10.004","article-title":"Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men","volume":"78","author":"Shoptaw","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1471-2458-6-214","article-title":"A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence","volume":"18","author":"Shoptaw","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1037\/1064-1297.14.4.413","article-title":"Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine","volume":"14","author":"Stoops","year":"2006","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0150","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0269881104047281","article-title":"Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans","volume":"18","author":"Stoops","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-005-0044-1","article-title":"Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration","volume":"182","author":"Stoops","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.drugalcdep.2006.02.004","article-title":"A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine","volume":"84","author":"Stoops","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pbb.2007.03.016","article-title":"Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans","volume":"87","author":"Stoops","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0170","series-title":"Results from the 2011 National Survey on Drug Use and Health: summary of national findings, NSDUH Series H-44, HHS Publication No. (SMA) 12-4713","author":"Substance Abuse","year":"2012"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0175","article-title":"A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis","volume":"1\u20138","author":"Sulaiman","year":"2012","journal-title":"Int J Psychiatry Clin Early Online"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0180","first-page":"1163","article-title":"Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs","volume":"285","author":"Tidey","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0185","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.164.1.160","article-title":"A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence","volume":"164","author":"Tiihonen","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(02)00104-7","article-title":"The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers","volume":"68","author":"Wachtel","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0195","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/sj.npp.1301353","article-title":"Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration","volume":"32","author":"Wee","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2005.06.035","article-title":"Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex","volume":"387","author":"Zocchi","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2013.08.007_bb0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10550490490436055","article-title":"Psychiatric symptoms in methamphetamine users","volume":"13","author":"Zweben","year":"2004","journal-title":"Am J Addict"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613001735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613001735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T04:18:44Z","timestamp":1563769124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584613001735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":41,"alternative-id":["S0278584613001735"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.08.007","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}